• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

当前失眠障碍模型:理论综述了孤啡肽能通路的潜在作用及其对失眠治疗的意义。

Current models of insomnia disorder: a theoretical review on the potential role of the orexinergic pathway with implications for insomnia treatment.

机构信息

Department of Clinical and Experimental Medicine, Unit of Psychiatry, Azienda Ospedaliero Universitaria Pisana AUOP, Pisa, Italy.

Département de Psychiatrie et D'Addictologie, AP-HP, GHU Paris Nord, DMU Neurosciences, Hopital Bichat - Claude Bernard, Paris, France.

出版信息

J Sleep Res. 2023 Aug;32(4):e13825. doi: 10.1111/jsr.13825. Epub 2023 Feb 14.

DOI:10.1111/jsr.13825
PMID:36786121
Abstract

Insomnia disorder is considered as a stress-related disorder associated with hyperarousal, stress and emotion dysregulation and the instability of the 'flip-flop' switch system. The orexinergic system is well known for its key role in sleep and arousal processes but also in the allostatic system regulating stress and emotions and may thus be of major interest for insomnia and its treatment. Accordingly, we discuss the potential role of orexins on sleep processes, brain systems modulating stress and emotions with potential implications for insomnia pathophysiology. We reviewed available data on the effect of dual orexin receptor antagonists (DORAs) on sleep and brain systems modulating stress/emotions with implications for insomnia treatment. We present our findings as a narrative review. Few data in animals and humans have reported that disrupted sleep and insomnia may be related to the overactivation of orexinergic system, while some more consistent data in humans and animals reported the overactivation of orexins in response to acute stress and in stress-related disorders. Taken together these findings may let us hypothesise that an orexins overactivation may be associated with stress-related hyperarousal and the hyperactivation of arousal-promoting systems in insomnia. On the other hand, it is possible that by rebalancing orexins with DORAs we may regulate both sleep and allostatic systems, in turn, contributing to a 'switch off' of hyperarousal in insomnia. Nevertheless, more studies are needed to clarify the role of the orexin system in insomnia and to evaluate the effects of DORAs on sleep, stress and emotions regulating systems.

摘要

失眠障碍被认为是一种与过度觉醒、应激和情绪调节障碍以及“翻转开关”系统不稳定相关的应激相关障碍。食欲肽系统在睡眠和觉醒过程中起着关键作用,在调节应激和情绪的适应系统中也起着重要作用,因此,它可能是失眠及其治疗的主要关注点。相应地,我们讨论了食欲肽对睡眠过程、调节应激和情绪的脑系统的潜在作用及其对失眠病理生理学的潜在影响。我们回顾了关于双重食欲肽受体拮抗剂(DORAs)对睡眠和调节应激/情绪的脑系统的影响的现有数据,这些数据对失眠治疗具有重要意义。我们以叙述性综述的形式呈现我们的发现。动物和人类的一些数据表明,睡眠中断和失眠可能与食欲肽系统的过度激活有关,而一些在人类和动物中更一致的数据则表明,食欲肽在急性应激和应激相关障碍中过度激活。这些发现表明,食欲肽的过度激活可能与应激相关的过度觉醒和失眠中觉醒促进系统的过度激活有关。另一方面,通过用 DORAs 来重新平衡食欲肽,我们可能会调节睡眠和适应系统,从而有助于失眠中的过度觉醒“关闭”。然而,还需要更多的研究来阐明食欲肽系统在失眠中的作用,并评估 DORAs 对睡眠、应激和情绪调节系统的影响。

相似文献

1
Current models of insomnia disorder: a theoretical review on the potential role of the orexinergic pathway with implications for insomnia treatment.当前失眠障碍模型:理论综述了孤啡肽能通路的潜在作用及其对失眠治疗的意义。
J Sleep Res. 2023 Aug;32(4):e13825. doi: 10.1111/jsr.13825. Epub 2023 Feb 14.
2
Emerging role of orexin antagonists in insomnia therapeutics: An update on SORAs and DORAs.食欲素拮抗剂在失眠治疗中的新作用:选择性食欲素受体拮抗剂(SORAs)和双重食欲素受体拮抗剂(DORAs)的最新进展
Pharmacol Rep. 2016 Apr;68(2):231-42. doi: 10.1016/j.pharep.2015.09.002. Epub 2015 Sep 28.
3
Clinical usefulness of dual orexin receptor antagonism beyond insomnia: Neurological and psychiatric comorbidities.双重食欲素受体拮抗剂在失眠症之外的临床应用:神经和精神共病。
Neuropharmacology. 2024 Mar 1;245:109815. doi: 10.1016/j.neuropharm.2023.109815. Epub 2023 Dec 17.
4
Evaluating the role of orexins in the pathophysiology and treatment of depression: A comprehensive review.评估食欲素在抑郁症病理生理学和治疗中的作用:全面综述。
Prog Neuropsychopharmacol Biol Psychiatry. 2019 Jun 8;92:1-7. doi: 10.1016/j.pnpbp.2018.12.008. Epub 2018 Dec 18.
5
Orexin Receptor Antagonists and Insomnia.食欲素受体拮抗剂与失眠
Curr Psychiatry Rep. 2022 Oct;24(10):509-521. doi: 10.1007/s11920-022-01357-w. Epub 2022 Aug 16.
6
Sleep-wake and arousal dysfunctions in post-traumatic stress disorder: Role of orexin systems.创伤后应激障碍的睡眠-觉醒和觉醒障碍:orexin 系统的作用。
Brain Res Bull. 2022 Aug;186:106-122. doi: 10.1016/j.brainresbull.2022.05.006. Epub 2022 May 23.
7
Clinical pharmacology, efficacy, and safety of orexin receptor antagonists for the treatment of insomnia disorders.临床药理学、疗效和安全性的食欲素受体拮抗剂治疗失眠障碍。
Expert Opin Drug Metab Toxicol. 2020 Nov;16(11):1063-1078. doi: 10.1080/17425255.2020.1817380. Epub 2020 Oct 4.
8
Orexin OX Receptor Antagonists as Sleep Aids.食欲素OX受体拮抗剂作为助眠药物。
Curr Top Behav Neurosci. 2017;33:105-136. doi: 10.1007/7854_2016_47.
9
The Discovery of Suvorexant, the First Orexin Receptor Drug for Insomnia.苏沃雷生的发现:失眠的第一种食欲素受体药物。
Annu Rev Pharmacol Toxicol. 2017 Jan 6;57:509-533. doi: 10.1146/annurev-pharmtox-010716-104837.
10
The orexin story and orexin receptor antagonists for the treatment of insomnia.食欲肽的故事与食欲肽受体拮抗剂治疗失眠症。
J Sleep Res. 2023 Dec;32(6):e13902. doi: 10.1111/jsr.13902. Epub 2023 Apr 22.

引用本文的文献

1
Targeting the Orexin System in the Pharmacological Management of Insomnia and Other Diseases: Suvorexant, Lemborexant, Daridorexant, and Novel Experimental Agents.针对食欲素系统进行失眠及其他疾病的药物治疗:苏沃雷生、伦博雷生、达利雷生及新型实验药物
Int J Mol Sci. 2025 Sep 6;26(17):8700. doi: 10.3390/ijms26178700.
2
Sleep Medicine-What's in a Name?睡眠医学——名称里有什么?
J Sleep Res. 2025 Oct;34(5):e70150. doi: 10.1111/jsr.70150. Epub 2025 Jul 19.
3
Insomnia, anxiety and related disorders: a systematic review on clinical and therapeutic perspective with potential mechanisms underlying their complex link.
失眠、焦虑及相关障碍:基于临床与治疗视角及潜在复杂关联机制的系统评价
Neurosci Appl. 2024 Jan 7;3:103936. doi: 10.1016/j.nsa.2024.103936. eCollection 2024.
4
Sleep Loss and Substance Use Disorders: An Issue from Adolescents to Adults.睡眠不足与物质使用障碍:从青少年到成年人的一个问题。
Behav Sci (Basel). 2025 Feb 15;15(2):220. doi: 10.3390/bs15020220.
5
Effects of Approved Pharmacological Interventions for Insomnia on Mood Disorders: A Systematic Review.失眠的获批药物干预对情绪障碍的影响:一项系统评价
Clin Neuropsychiatry. 2024 Oct;21(5):385-402. doi: 10.36131/cnfioritieditore20240504.
6
Pharmacokinetics, safety, and efficacy of daridorexant in Japanese subjects: Results from phase 1 and 2 studies.达利多雷克斯安在日本受试者中的药代动力学、安全性和疗效:1期和2期研究结果
J Sleep Res. 2025 Feb;34(1):e14302. doi: 10.1111/jsr.14302. Epub 2024 Aug 8.
7
Hyperarousal features in the sleep architecture of individuals with and without insomnia.有失眠症和无失眠症个体睡眠结构中的高觉醒特征。
J Sleep Res. 2025 Feb;34(1):e14256. doi: 10.1111/jsr.14256. Epub 2024 Jun 9.
8
Effect of daridorexant on sleep architecture in patients with chronic insomnia disorder: a pooled post hoc analysis of two randomized phase 3 clinical studies.达力雷汀对慢性失眠障碍患者睡眠结构的影响:两项随机 3 期临床研究的汇总事后分析。
Sleep. 2024 Nov 8;47(11). doi: 10.1093/sleep/zsae098.
9
Insomnia: A Current Review.失眠:当前综述。
Mo Med. 2024 Jan-Feb;121(1):44-51.
10
Evaluation and management of insomnia in the clinical practice in Italy: a 2023 update from the Insomnia Expert Consensus Group.意大利临床实践中失眠的评估与管理:失眠专家共识组 2023 年更新。
J Neurol. 2024 Apr;271(4):1668-1679. doi: 10.1007/s00415-023-12112-3. Epub 2023 Dec 8.